We need a strong catalyst for a short covering. With all the institutions supporting this, how they let the bs short hedge funds manipulate this is beyond me. Why they let this close so far below the 200 moving day is beyond me. CEO needs to bring his A game at tomorrow monrnings investor day conference call.
Shorts are in real trouble here. They've doubled down and significantly increased their short position after the last analyst recommending an over bought position. Company will be coming out with positive news soon and volume is decreasing. we should see a nice spike with news in a week or so. Will be well worth the wait. Price is 96.74 as I type this
A little optimistic but possible. I have a few calls. I'm thinking the last 30 minutes of tomorrow's trading will be interesting.
Cause da Deal gettin Done. I knows it, you knows it, Europe knows it, and American savvy day traders knows it. :-D
I'll bet Esperion Management strongly disagrees with the PR today and the analyst rating to sell. Obvious short attack and total load of crock.
Don't expect the Short sellers to roll over but the close to 2 million shares short must be squirming seeing todays filing. Up $2+ premarket with very little selling. Shaping up to be a VERY good week for ESPR ;-D
On July 7, 2015, Esperion Therapeutics, Inc. issued a press release titled, “Esperion Therapeutics Announces Removal of 240 mg Partial Clinical Hold for ETC-1002” (the “Press Release”). A copy of the Press Release is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
I thought the CEO of Esperion expressed that he did not feel their label will be restrictive. Maybe I misinterpreted his comments. Also seems to me that a pill form versus an injection will be far more successful. Plus it works like a statin to regulate LDL Receptors, lowering hsCRP, with lower potential muscle side effects. I think they are looking at dominating a market of 11 million patients and I'm betting they will. They are also well funded through NDA. Strong management team.... Btw, I am not an investor in REGN. I do know about both REGN and AMGN but I am only a small investor in ESPR.
And don't think for a second these large institutional investors and hedgefunds don't see the vast potential with MINIMAL risk. These guys have done it before and will don it again in a very big way.
If you have not had an opportunity to go to the Esperion website and listen to the CEO's presentation, you really need to do yourself a favor and take 25 minutes and listen and follow along with the slides. Go to the Investors button in the upper right hand corner of their website and go down to the 2nd option: Events and Presentations. Very informative and super exciting. More people die from Cardiovascular disease than anything else in the world and especially the US. This drug is the ONLY one of it's kind that reduces LDL bad colesterol without the Statin. Nothing else like it is in development. 25 Billion dollar market and this drug will dominiate it. I can imagine in 5 years seeing a 500% return on investment as a very real possibility.
Feeling good about taking a long position. Not much selling and looks to be a couple million shares short that need to cover. Looking forward to the conference call next Tuesday. GL Longs.